Cargando…
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
Cancer patients have increased morbidity and mortality from Coronavirus Disease 2019 (COVID-19), but the underlying immune mechanisms are unknown. In a cohort of 100 cancer patients hospitalized for COVID-19 at the University of Pennsylvania Health System, we found that patients with hematologic can...
Ejemplares similares
-
High-throughput interrogation of immune responses using the Human Immune Profiling Pipeline
por: Wang, Guanning, et al.
Publicado: (2023) -
Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 T cell responses
por: Lyudovyk, Olga, et al.
Publicado: (2022) -
Discordant SARS-CoV-2 spike protein receptor binding domain IgG and neutralization after B-cell depletion
por: Noy, Ariela, et al.
Publicado: (2022) -
The many faces of the anti-COVID immune response
por: Vardhana, Santosha A., et al.
Publicado: (2020) -
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival
por: Boursi, Ben, et al.
Publicado: (2023)